• HOME
  • OUR SERVICES
  • RESOURCES
  • EDUCATION
  • PROVIDERS
instagram-color-circle-outline
facebook-color-circle-outline

HEALTH CORNER PEDIATRICS

PATIENT PORTAL

PAY ONLINE

SEND US A MESSAGE

Privacy Policy

New Born Care/New Born Screening

New Born Care/New Born Screening

TRUST THE EXPERTS

New Born Care/New Born Screening

Shortly after birth, while still in the hospital, newborn infants are screened for serious genetic and medical conditions. Newborn screening is intended to identify children at increased risk for selected genetic, infectious, or other congenital disorders at the earliest stages.

Newborn screenings allow doctors to educate families and ensure that babies with abnormal test results receive additional testing and treatment. With early diagnosis, treatment can begin right away, before serious problems occur or lifelong health problems begin.

Screening tests for newborn infants may vary by state. While all states require newborn screenings for all babies born in the state, each state determines which disorders are part of their screening program. Newborn infants are typically screened for the following disorders

OUR SERVICES

PATIENT RESOURCES

Phenylketonuria (PKU)

Congenital hypothyroidism

Galactosemia

Tyrosinemia

Cystic fibrosis

Toxoplasmosis

The newborn infant is usually screened within the first 24 hours of life. The screening is performed through a simple blood test. During the blood test, which is sometimes referred to as a heel stick, the baby's heel is pricked to collect a small sample of blood. The test for PKU may need to be repeated if the infant is tested too soon after birth.  Additional newborn screening tests may include: Hearing tests to determine if the baby's ears respond to sound.

Some states require babies to undergo a second newborn screening when they are two weeks old. This ensures the most accurate results from the screening tests. If a hearing test is not conducted while the infant is in the hospital, the child should be screened during the first three weeks of life.

The results of the newborn screening tests are obtained by the doctor and discussed directly with the parents of the infant.  Abnormal test results from a newborn screening do not necessarily indicate the presence of a disorder. They do indicate, however, the need for further diagnostic testing. The initial screening provides only preliminary information that must be followed up with more specific diagnostic testing.  If additional testing confirms that an infant does have a disorder, patients may be referred to a specialist for further evaluation and treatment.

Medium-chain acyl-CoA dehydrogenase (MCAD ) deficien

cySickle cell disease

Biotinidase deficiency

Congenital adrenal hyperplasia

Maple syrup urine disease (MSUD)

business hours

MONDAY-FRIDAY8:30 AM - 5:00 PM

DO YOU NEED AN APPOINTMENT?

IS EASY! JUST TEXT US!

Phone (915) 642-7004

We use the latest HIPPA compliant

communication technology!

 

Call or Text!

Texting is Faster!!!

 

MAKE AN APPOINTMENT

We take care of children from birth through age 21

The newborn infant is usually screened within the first 24 hours of life. The screening is performed through a simple blood test. During the blood test, which is sometimes referred to as a heel stick, the baby's heel is pricked to collect a small sample of blood. The test for PKU may need to be repeated if the infant is tested too soon after birth.  Additional newborn screening tests may include: Hearing tests to determine if the baby's ears respond to sound.

 

Some states require babies to undergo a second newborn screening when they are two weeks old. This ensures the most accurate results from the screening tests. If a hearing test is not conducted while the infant is in the hospital, the child should be screened during the first three weeks of life.

 

The results of the newborn screening tests are obtained by the doctor and discussed directly with the parents of the infant.  Abnormal test results from a newborn screening do not necessarily indicate the presence of a disorder. They do indicate, however, the need for further diagnostic testing. The initial screening provides only preliminary information that must be followed up with more specific diagnostic testing.  If additional testing confirms that an infant does have a disorder, patients may be referred to a specialist for further evaluation and treatment.

Our mission is to provide the highest quality medical care from birth through adolescence to the children of El Paso TX

New Born Care/New Born Screening

Shortly after birth, while still in the hospital, newborn infants are screened for serious genetic and medical conditions. Newborn screening is intended to identify children at increased risk for selected genetic, infectious, or other congenital disorders at the earliest stages.

 

Newborn screenings allow doctors to educate families and ensure that babies with abnormal test results receive additional testing and treatment. With early diagnosis, treatment can begin right away, before serious problems occur or lifelong health problems begin.

 

Screening tests for newborn infants may vary by state. While all states require newborn screenings for all babies born in the state, each state determines which disorders are part of their screening program. Newborn infants are typically screened for the following disorders

PATIENT RESOURCES

VIEW OUR SERVICES

We use the latest HIPPA compliant communication technology!    Call or Text! Texting is faster!!!

Hello! I would like to request an appointment!

Great :)

Want to schedule a visit? It's as easy as texting us!!!

READ 2:05PM

DELIVERED

DELIVERED

Hi, yes I will be happy to help you? Let me know when would you like to be seen by the doctor.

Regular Office Hours

Monday – Friday

8:30 am-05:00 pm

After Hours Clinic

4:00 - 7:00 pm

Walk in patients are Welcome!!

Extended Office Hours

 

Saturday by appointment only

8:45 am-11:45 am

VIEW OUR SERVICES

Phenylketonuria (PKU)

Congenital hypothyroidism

Galactosemia

Tyrosinemia

Cystic fibrosis

Toxoplasmosis

Medium-chain acyl-CoA dehydrogenase (MCAD ) deficiency

Sickle cell disease

Biotinidase deficiency

Congenital adrenal hyperplasia

Maple syrup urine disease (MSUD)